Kernal Biologics Announces $25M Series A Financing To Advance Its Mrna 2.0 Technology For Oncology

Kernal Biologics Announces $25M Series A Financing To Advance Its Mrna 2.0 Technology For Oncology

07/07/22, 7:00 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgcambridge
Money raised
$25 million
Round Type
series a
Kernal Biologics, Inc. (Kernal Bio) — a development-stage mRNA-technology company developing cancer therapeutics designed to improve patients' survival rate and quality of life — today announced the completion of a $25 million Series A financing led by Hummingbird Ventures. Amgen Ventures, HBM Genomics and Civilization Ventures along with other VCs, family offices and high net worth individuals also participated in the round.

Company Info

Company
Kernal Biologics
Location
cambridge, maryland, united states
Additional Info
Kernal biologics is an onco-selective mRNA therapeutics company located in Cambridge, MA